NasdaqCM - Delayed Quote • USD
MiNK Therapeutics, Inc. (INKT)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 7:22 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -0.15 | -0.13 | -0.56 | -0.6 |
| Low Estimate | -0.17 | -0.16 | -0.66 | -0.64 |
| High Estimate | -0.14 | -0.11 | -0.51 | -0.54 |
| Year Ago EPS | -0.17 | -0.18 | -0.65 | -0.56 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 3 | 3 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.24 | -0.2 | -0.18 | -0.15 |
| EPS Actual | -0.17 | -0.18 | -0.15 | -0.16 |
| Difference | 0.07 | 0.02 | 0.03 | -0.01 |
| Surprise % | 29.20% | 10.00% | 16.70% | -6.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.15 | -0.13 | -0.56 | -0.6 |
| 7 Days Ago | -0.15 | -0.13 | -0.56 | -0.6 |
| 30 Days Ago | -0.15 | -0.13 | -0.56 | -0.6 |
| 60 Days Ago | -0.15 | -0.14 | -0.63 | -0.78 |
| 90 Days Ago | -0.15 | -0.14 | -0.63 | -0.78 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | INKT | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 11.80% | -- | -- | 6.50% |
| Next Qtr. | 27.80% | -- | -- | 12.00% |
| Current Year | 13.80% | -- | -- | 5.30% |
| Next Year | -7.10% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/21/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/10/2023 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/12/2023 |
| Reiterates | HC Wainwright & Co.: Buy | 4/19/2023 |
| Maintains | Evercore ISI Group: Outperform | 3/22/2023 |
| Reiterates | HC Wainwright & Co.: Buy | 3/22/2023 |
Related Tickers
AGEN Agenus Inc.
11.69
+40.84%
PTIX Protagenic Therapeutics, Inc.
1.3850
-4.48%
IKT Inhibikase Therapeutics, Inc.
1.7100
-8.06%
MBIO Mustang Bio, Inc.
0.3161
-11.58%
LIXT Lixte Biotechnology Holdings, Inc.
3.2600
+0.31%
MGNX MacroGenics, Inc.
14.56
+1.32%
XLO Xilio Therapeutics, Inc.
1.0900
+7.92%
ATHE Alterity Therapeutics Limited
2.5100
+9.61%
CTMX CytomX Therapeutics, Inc.
1.5900
-0.62%
ALZN Alzamend Neuro, Inc.
0.7195
-0.90%